Project description:RUNX1-ETO knockdown was performed in Kasumi-1 cells and transcriptomic analyses by RNA-sequencing were performed at two different time points (day2 and day9). Control cells (Kasumi-1 shControl) were also analysed at day2 and day9. All samples were analysed in triplicates.
Project description:Samples of adherent and suspension cells undergoing reprogramming were collected at day 0, day2, day6, day15 (with doxycycline) and day25 (without doxycycline).
Project description:Next-generation proteomics of Vero E6 cells infected by Italy-INMI1 SARS-CoV-2 virus for defining the kinetics of whole viral particle antigen production for vaccines. Cells from Day1, Day2, Day3, Day4, Day7 post-infection at two multiplicities of infection.
Project description:In order to identify potential mechanisms involved in cardioprotection by IGF1 we performed microarray analysis of the infarcted areas on day1, day2, and day7 after acute myocardial infarction.
Project description:We profiled miRNAs from embryonic stem cells to motor neurons derived via RA (retinoic acid) and distinguished different developmental stages by days. Those developmental stages are ESC, Day2, Day3, Day4, and both motor neuron and interneuron with day7. We also provide the fractionated nuclear and cytoplasm miRNA profiling with motor neuron and interneuron respectivey.
Project description:RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation .